Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

NERV

+ Watchlist+ Portfolio

Minerva Neurosciences, Inc

Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$2.16
52-Week Range
$1.96 – $8.80
Market Cap
$108.64M
P/E (TTM)
—
EPS (TTM)
-33.83
Dividend Yield
0.00%
Advanced Metrics
Price/Book
—
PEG Ratio
—
Return on Equity
—
Return on Assets
-34.75%
Gross Margin
0.00%
Operating Margin
0.00%
Profit Margin
0.00%
Current Ratio
33.02
Debt/Equity
—
Total Debt
$60.00M
Free Cash Flow
$-13.18M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$103.44M

Market Snapshot

About

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company developing therapeutics for central nervous system disorders. The company focuses on treatments for schizophrenia, insomnia, depression, and Parkinson disease.